University of Ibadan   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Ibadan Nigeria (1948)

Organization Overview

First Clinical Trial
2014
NCT02149537
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

ADEOYO MATERNITY TEACHING HOSPITAL, IBADAN, OYO STATE | College of Medicine, University of Ibadan, Nigeria | institute for advanced medical research and training, UI, IBADAN | Institute for Advanced Medical Research and Training, University of Ibadan, Ibadan | ORIYOMI OMOTOYOSI AKINYOTU | Titilayo O Fakeye | University College Hospital, Ibadan | UNIVERSITY COLLEGE HOSPITAL, IBADAN, OYO STATE, NIGERIA | UNIVERSITY COLLEGE HOSPITAL,IBADAN,OYO STATE,NIGERIA | UNIVERSITY COLLEGE HOSPITAL,IBADAN,OYO STATE, NIGERIA | University of Ibadan | University of Ibadan College of Medicine, Nigeria

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Sickle Cell (Phase 4)

Hypertension (Phase 4)

Malaria (Phase 1)

Pleural Effusion (Phase 1)

Pleural Effusion, Malignant (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 27